Tumor Microenvironment Composition and Severe Cytokine Release Syndrome (CRS) Influence Toxicity in Patients with Large B-Cell Lymphoma Treated with Axicabtagene Ciloleucel-Reference-Cited by-同舟云学术

Tumor Microenvironment Composition and Severe Cytokine Release Syndrome (CRS) Influence Toxicity in Patients with Large B-Cell Lymphoma Treated with Axicabtagene Ciloleucel

Published:2020-07-15 Issue:18 Volume:26 Page:4823-4831
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Faramand Rawan,Jain Michael^ORCID,Staedtke Verena,Kotani Hiroshi^ORCID,Bai Renyuan,Reid Kayla,Lee Sae Bom,Spitler Kristen,Wang Xuefeng^ORCID,Cao Biwei,Pinilla Javier,Lazaryan Aleksander^ORCID,Khimani Farhad,Shah Bijal,Chavez Julio C.,Nishihori Taiga,Mishra Asmita,Mullinax John^ORCID,Gonzalez Ricardo,Hussaini Mohammad,Dam Marian,Brandjes Brigett D.,Bachmeier Christina A.^ORCID,Anasetti Claudio,Locke Frederick L.^ORCID,Davila Marco L.^ORCID

Funder

NCI

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chimeric antigen receptor T‐cell therapy for haematological malignancies: Insights from fundamental and translational research to bedside practice;British Journal of Haematology;2024-09-11

2. Immune prognostic score predicts the risk of infection and survival outcomes in patients with relapsed multiple myeloma treated with bispecific antibodies;British Journal of Haematology;2024-08-27

3. Tocilizumab Prophylaxis Following Axicabtagene Ciloleucel in Relapsed or Refractory Large B-Cell Lymphoma;Transplantation and Cellular Therapy;2024-08

4. Rapid identification of early infections in febrile patients after CD19 target CAR-T cell therapy for B-cell malignancies;Journal of Translational Medicine;2024-07-02

5. CAR-T cell therapy: Efficacy in management of cancers, adverse effects, dose-limiting toxicities and long-term follow up;International Immunopharmacology;2024-06